Patents by Inventor Matthew P. Scaramozza

Matthew P. Scaramozza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240216330
    Abstract: The present disclosure provides combination therapies for treating an autoimmune disease in a subject in need thereof. The methods comprise administering to the subject an effective amount of a BTK inhibitor in combination with an effective amount of a fumaric acid ester (FAE). The autoimmune disease can be treated include, for example, multiple sclerosis (MS), lupus, rheumatoid arthritis (RA), Pemphigus Vugaris (PV), neuromyelitis optica (NMO), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), anti-NMDA receptor encephalitis, or Sjogren's disease.
    Type: Application
    Filed: April 1, 2022
    Publication date: July 4, 2024
    Inventors: Michael Joseph Palte, Brian T. Hopkins, Matthew P. Scaramozza, Michael Christian Mingueneau, Alex Pellerin, Chelsea R. Parker Harp, Catherine Barbey